US Bancorp’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

US Bancorp’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$51	–	4268
2022 Q4	$51	Hold	2	–	–	﹤0.01%	4101
2022 Q3	$0	Hold	2	–	–	﹤0.01%	4291
2022 Q2	$0	Hold	2	–	–	﹤0.01%	4312
2022 Q1	$0	Buy	+2	New	+$759	﹤0.01%	4270
2020 Q3	–	Sell	-1	Closed	-$2K	–	3909
2020 Q2	$2K	Buy	+1	New	+$2.72K	﹤0.01%	3553

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

US Bancorp's BIOR Position: Q1 2023 in Review

US Bancorp sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 2 shares — an estimated $51 sold.

US Bancorp first reported a position in BIOR in Q2 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

US Bancorp reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
US Bancorp sold 2 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $51.
US Bancorp first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
US Bancorp's Biora Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2020.
30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.